Ocular Therapeutix
Develops hydrogel-delivered retinal therapies and commercial ophthalmic drug inserts.
$10.45
After-hours close+0.09 (+0.87%)
At close$10.36(−4.25%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.36 | — | — |
| Aug 2026 | −$0.40 | — | — |
| Aug 2026 | −$0.40 | −$0.35 | +11.5% |
| May 2026 | −$0.32 | −$0.41 | −28.1% |
| Feb 2026 | −$0.33 | −$0.29 | +12.1% |
| Nov 2025 | −$0.39 | −$0.37 | +5.1% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.36 | — | — | $14.3M | — | — |
| Aug 4, 2026 | −$0.40 | — | — | $13.2M | — | — |
| Aug 3, 2026 | −$0.40 | −$0.35 | +11.5% | $13.2M | $13.5M | +2.1% |
| May 5, 2026 | −$0.32 | −$0.41 | −28.1% | $12.7M | $10.8M | −15.2% |
| Feb 5, 2026 | −$0.33 | −$0.29 | +12.1% | $16.1M | $13.3M | −17.8% |
| Nov 4, 2025 | −$0.39 | −$0.37 | +5.1% | $16.1M | $14.5M | −9.9% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 5, 2025 | ||||||
| Mar 3, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 11, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Mar 6, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 5, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 7, 2020 | ||||||
| May 8, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 10, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 8, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 5, 2017 | ||||||
| Mar 10, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 10, 2016 | ||||||
| Nov 10, 2015 | ||||||